UroGen Pharma
URGN
URGN
60 hedge funds and large institutions have $111M invested in UroGen Pharma in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 23 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
8% less funds holding
Funds holding: 65 → 60 (-5)
50% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 10
61% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 23
Holders
60
Holding in Top 10
1
Calls
$407K
Puts
$1K
Top Buyers
| 1 | +$1.32M | |
| 2 | +$682K | |
| 3 | +$321K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$148K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$114K |
Top Sellers
| 1 | -$1.47M | |
| 2 | -$320K | |
| 3 | -$300K | |
| 4 |
State Street
Boston,
Massachusetts
|
-$275K |
| 5 |
MMH
Menora Mivtachim Holdings
Ramat Gan,
Israel
|
-$254K |